The effect of inhibiting angiogenesis of low-dose hydroxycamptothecine and cyclophosphamice Combine Themotherapy for cancer patients
QIAN Xiao-ping,LIU Bao-rui,HU Jing,HU Wen-jing,ZOU Zheng-yun,YIN Hai-tao,KONG Wei-wei,YANG Yang
DOI: https://doi.org/10.3969/j.issn.1672-4992.2007.08.030
2007-01-01
Journal of Modern Oncology
Abstract:Objective:To observe the effect of hydroxycamptothecine and cyclophosphamide in the treatment of hepatoma,carcinoma of gallbladder,pancreatic cancer and tumor of relapsing refractory.Methods:twenty-seven patients with advanced solid tumors were enrolled in this phase III~IV trial,whom had received at least one prior chemotherapy regimen.All patients received oral cyclophosphamide(50mg) daily in addition to twice weekly injec tions of hydroxycamptothecine(5mg).Fifteen of the patients also received themotherapy twice weekly with the intent of further inhibiting tumor angiogenesis.The primary end point of the study was clinical benefit,defined as the percentage of patients experiencing an objective response or middle survival time,change of the value of VEGF.Results:For the eligible patients in the group of only chemotherapy,response rate was 58.33%(7/12 SD).Clinical benefit of twelve patients for an overall objective response was 58.33%;median survival time 11.2 months;the decrease of VEGF 41.67%.For the eligible patients in the group with thermotherapy,response rate was 80%(2/15 PR,10/15 SD).Clinical benefit of an additional fifteen patients 66.7%;median survival time 19.2 months;the decrease of VEGF 60%.Conclusion:This low-dose regimen chemotherapy consisting of daily oral cyclophosphamide and twice weekly hydroxycamptothecine injections could raise response rate,improve clinical benefit,prolong survival time to patients with hepatoma,carcinoma of gallbladder,pancreatic cancer and tumor of relapsing refractory.The patients treatod concurrently with themotherapy showed significant synergistic effect with minimal toxicity.Low dose hydroxycamptothecin and cyclophosphamide maybe have antiangiogenesis effect.